Global Medical Device Industry Statistics Show Production Of Non-COVID Equipment Is Severely Impacted

NEXT STORY
SpringWorks Therapeutics Announces Collaboration with Children’s Oncology Group to Conduct a Phase 2 Clinical Trial of Nirogacestat in Pediatric Patients with Desmoid Tumors and Reports Publication of Nirogacestat Case Series in Pediatric/Young Adult Desmoid Tumor Patients
PREV STORY
mHealth Apps Market size is projected to reach USD 57.57 billion with 21.1% CAGR till 2026; Driven by Increasing Investment in the Development of Newer Products, says Fortune Business Insights™
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Merus gibt Finanzergebnisse für das zweite Quartal bekannt und legt ein Update zur Geschäftsentwicklung vor

author_avatar
NASDAQ Market News

OSE Immunotherapeutics and Nantes University Hospital Announce Initiation of a Phase 1/2 Clinical Trial to Evaluate CD28 Antagonist FR104 in Patients Undergoing Renal Transplantation

author_avatar
NASDAQ Market News

Nabriva Therapeutics Announces Retirement of its Chief Financial Officer

author_avatar
NASDAQ Market News